DENVER (KDVR) — A global contract development and manufacturing organization with headquarters in Seattle has announced the closure of its Boulder and Longmont locations, resulting in hundreds of laid-off workers in Colorado.
AGC Biologics filed a WARN Notice with the state of Colorado on Sept. 16 about the closure of its Boulder and Longmont facilities, as well as the impact on employees who support those facilities from afar.
On its website, the company says that it provides pharmaceutical development and manufacturing services for protein-based biologics, cell and gene therapies and messenger RNA. It boasts eight locations across the world, including in Japan, Denmark, Italy and Germany, but will drop to six after the two Colorado locations are shuttered.
The two locations closing will result in the state losing dozens of engineering and manufacturing jobs — 73 positions slated to be cut are designated as engineer jobs, with another 81 manufacturing jobs on the chopping block. In total, the company is laying off 267 employees in Colorado, but 278 across the nation.
Of those employees, 218 are at the Boulder location, which is billed on the company’s website as a “mammalian large-scale commercial manufacturing” facility. Another 48 employees from the Longmont location will lose their jobs, as well as:
- 1 employee in Kremmling
- 9 employees in Bothell, Washington
- 1 employee in Klamath Falls, Oregon
- 1 employee in Newton Square, Pennsylvania
The company said in its WARN notice that it will be separating from “many” of the employees on Nov. 15, and the rest on Dec. 31.
Want more insights? Join Working Title - our career elevating newsletter and get the future of work delivered weekly.
